Jhanelle Gray, MD
Internal Medicine · Tampa, FLNPI 1376599340
Payments from drug & device makers
Across 718 payments — averaging $28,952 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$16.9M
- Pfizer$1.2M
- AstraZeneca$1.1M
- E.r. Squibb & Sons, L.L.C.$404K
- Genentech, Inc.$269K
- Janssen Research & Development, LLC$248K
- plus $676K from 26 others
Across 11 payments — averaging $1644.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$14K
- Novartis$2K
- Regeneron$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 149 | $16,945,483 |
| Pfizer | 208 | $1,183,436 |
| AstraZeneca | 44 | $1,061,167 |
| E.r. Squibb & Sons, L.L.C. | 14 | $404,421 |
| Genentech, Inc. | 64 | $269,011 |
| Janssen Research & Development, LLC | 5 | $248,307 |
| Array Biopharma Inc | 14 | $148,249 |
| Novartis | 22 | $141,425 |
| Regeneron | 48 | $108,543 |
| Daiichi Sankyo Inc. | 58 | $71,834 |
| Gilead | 11 | $56,979 |
| Spectrum Pharmaceuticals Inc. | 2 | $22,024 |
| EMD Serono, Inc. | 15 | $21,049 |
| Astrazeneca UK Limited | 12 | $18,436 |
| G1 Therapeutics, Inc. | 8 | $16,846 |
| Eli Lilly | 6 | $14,540 |
| Acerta Pharma LLC | 1 | $10,173 |
| Johnson & Johnson | 5 | $9,238 |
| Amgen | 4 | $5,555 |
| Jazz Pharmaceuticals Inc. | 2 | $5,144 |
| Blueprint Medicines Corporation | 3 | $4,756 |
| Janssen Scientific Affairs, LLC | 4 | $4,040 |
| Coherus Oncology, Inc. | 3 | $4,016 |
| Sanofi | 1 | $2,876 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $2,625 |
| AbbVie | 3 | $2,365 |
| Genentech USA, Inc. | 2 | $1,984 |
| Catalyst Pharmaceuticals, Inc. | 2 | $1,663 |
| Merck Kgaa | 2 | $1,208 |
| Astrazeneca AB | 3 | $158 |
| Regeneron Healthcare Solutions, Inc. | 1 | $101 |
| Novocure Inc. | 1 | $40 |
How this compares
$20,787,690 in reported general payments places this provider in the 95th percentile of 8,530 internal medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Tampa
- Sady AlpizarTampa$13.5M
- Karon LociceroTampa$6.6M
- Yaneicy Gonzalez RojasCoral Gables$93.5M
- Juan Carlos RondonHollywood$66.8M
- Jaynier MoyaPembroke Pines$45.4M
- Mark KutnerMiami$35.7M
- Gilberto JimenezHialeah$35.6M
- Mira BaronWest Palm Beach$29.6M
- William SanchezHialeah$28.9M
- Nelia Sanchez-CrespoHollywood$28.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.